Background illustration for clinical trials search

Paid Clinical Trials Auburn

Discover 62 paid clinical trials in Auburn, Alabama. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2

Combined Dose-Finding and CV Outcomes Study With CSL300 (Clazakizumab) in Adult Subjects With ESKD Undergoing Dialysis (POSIBIL6ESKD)

for
End Stage Kidney Disease
Location: Montgomery AL, Columbus GA, Douglasville GA, Cordele GA,
Sponsor: CSL Behring

Sex: All

Age: 18+

Code: NCT05485961

Phase2, Phase3, Recruiting

DeciPHer-ILD: A Real-world Patient Registry in Group 3 Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)

for
Pulmonary Hypertension Due to Lung Diseases and Hypoxia,
Location: Columbus GA, Birmingham AL, Atlanta GA, Anderson SC,
Sponsor: United Therapeutics

Sex: All

Age: 18+

Code: NCT06388421

Recruiting

LEVEL-2: LEVosimendan to Improve Exercise Limitation in Patients With PH-HFpEF-2

for
Pulmonary Hypertension Associated With HFpEF
Location: Alexander City AL, Nashville TN, New Orleans LA,
Sponsor: Tenax Therapeutics, Inc.

Sex: All

Age: 18 - 70+

Code: NCT07288398

Phase3, Recruiting

A Study of Modified Release RTN-001 In Patients With Uncontrolled Hypertension

for
Uncontrolled Hypertension
Location: Alexander City AL, Birmingham AL, Decatur GA,
Sponsor: Retension Pharmaceuticals. Inc.

Sex: All

Age: 18 - 70+

Code: NCT07142356

Phase2, Recruiting

Study to Evaluate the Effect of Balcinrenone/Dapagliflozin in Patients With Heart Failure and Impaired Kidney Function

for
Heart Failure and Impaired Kidney Function
Location: Alexander City AL, Peachtree City GA, Atlanta GA,
Sponsor: AstraZeneca

Sex: All

Age: 18 - 70+

Code: NCT06307652

Phase3, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

Reducing Adverse Vascular Outcomes With Factor XI Inhibition in Adult Participants With Peripheral Artery Disease

for
Peripheral Artery Disease (PAD)
Location: Alexander City AL, Panama City FL, Tullahoma TN,
Sponsor: Regeneron Pharmaceuticals

Sex: All

Age: 18+

Code: NCT07318610

Phase3, Recruiting

Study With Omecamtiv Mecarbil (CK-1827452) to Treat Chronic Heart Failure With Severely Reduced Ejection Fraction

for
Heart Failure, Heart Failure With Reduced Ejection Fraction
Location: Alexander City AL, Fayetteville GA, Birmingham AL,
Sponsor: Cytokinetics

Sex: All

Age: 18 - 70+

Code: NCT06736574

Phase3, Recruiting

Stroke and Systemic Embolism Prevention in Adult Participants With Atrial Fibrillation

for
Atrial Fibrillation (AF)
Location: Alexander City AL, Dothan AL, Atlanta GA,
Sponsor: Regeneron Pharmaceuticals

Sex: All

Age: 18+

Code: NCT07626411

Phase3, Recruiting

A Clinical Trial of MK-7262 and Enlicitide in Participants With High Lipoprotein(a) (MK-7262-004)

for
Lipoprotein(a)
Location: Alexander City AL, Mobile AL, Jacksonville FL,
Sponsor: Merck Sharp & Dohme LLC

Sex: All

Age: 18+

Code: NCT07614984

Phase2, Recruiting
New

AMAZE 9: A Research Study Investigating How Well Zenagamtide Tablets Help People With Excess Body Weight Lose Weight

for
Overweight, Obesity
Location: Montgomery AL, Anniston AL, Birmingham AL, Conyers GA,
Sponsor: Novo Nordisk A/S

Sex: All

Age: 18+

Code: NCT07720271

Phase3, Recruiting

AMBITION 7: A Research Study Investigating How Well Zenagamtide Lowers Blood Sugar and Body Weight Compared to Insulin Glargine in People With Type 2 Diabetes and Increased Risk of Diseases That Affect the Heart and Blood Vessels Treated With 1-3 Other Diabetes Medications

for
Type 2 Diabetes, Cardiovascular Risk
Location: Montgomery AL, Albany GA, Fairhope AL, Nashville TN,
Sponsor: Novo Nordisk A/S

Sex: All

Age: 45+

Code: NCT07797335

Phase3, Recruiting

This Study is a Non-interventional Disease Registry of Adolescent and Adult Patients With Atopic Dermatitis Who Initiate or Switch Any Systemic Treatment

for
Atopic Dermatitis
Location: Montgomery AL, Birmingham AL, Macon GA, Spartanburg SC,
Sponsor: Sanofi

Sex: All

Age: 12+

Code: NCT07290803

Recruiting

A Phase 2 Study of MZE829 in Adults With APOL1 Kidney Disease

for
Proteinuric Kidney Disease
Location: Montgomery AL, Riverdale GA, College Park GA, Macon GA,
Sponsor: Maze Therapeutics

Sex: All

Age: 18 - 68

Code: NCT06830629

Phase2, Recruiting

A Study to Investigate the Efficacy and Safety of Tezepelumab Compared With Placebo in Children 5 to < 12 Years Old With Severe Asthma

for
Asthma
Location: Montgomery AL, Atlanta GA, Chapel Hill NC,
Sponsor: AstraZeneca

Sex: All

Age: 5 - 11

Code: NCT06023589

Phase3, Recruiting

Rollover Study for Participants Previously Enrolled in Clinical Trials of Povorcitinib

for
Hidradenitis Suppurativa (HS)
Location: Montgomery AL, Birmingham AL, Stonecrest GA,
Sponsor: Incyte Corporation

Sex: All

Age: 18+

Code: NCT06855498

Phase3, Recruiting

Evaluating an Interactive Digital Toolkit for Women's PrEP Implementation

for
HIV Prevention, HIV Risk, Sexual and Reproductive Health
Location: Montgomery AL, Birmingham AL, Tuscaloosa AL,
Sponsor: University of Alabama at Birmingham

Sex: Female

Age: 18+

Code: NCT07292584

Recruiting

Manipulation and Dry Needling in Patients With Cervicogenic Headache and WAD II

for
Cervicogenic Headache, Whiplash Injuries
Location: Montgomery AL
Sponsor: Alabama Physical Therapy & Acupuncture

Sex: All

Age: 18 - 65

Code: NCT06502951

Recruiting

A Phase II Nationwide, Fully Decentralized, Telemedicine Study of Pemigatinib in Adult Patients With Advanced or Metastatic Pancreatic Cancer With FGFR Genetic Alterations

for
Advanced Pancreatic Carcinoma, Metastatic Pancreatic Carcinoma,
Location: Montgomery AL, Birmingham AL, Atlanta GA,
Sponsor: Sameek Roychowdhury

Sex: All

Age: 18+

Code: NCT06906562

Phase2, Recruiting
FeaturedActive & Responsive

A Study to Assess the Safety and Efficacy of Oral Armour Thyroid Compared to Synthetic T4 for the Treatment of Primary Hypothyroidism in Adult Participants

for
Hypothyroidism
Location: Columbus GA, Birmingham AL, Atlanta GA, Macon GA,
Sponsor: AbbVie

Sex: All

Age: 18 - 70+

Code: NCT06345339

Phase2, Phase3, Recruiting
Featured

A Study of Upadacitinib in Adult Participants With Moderate-to-Severe Atopic Dermatitis and Inadequate Response to Dupilumab

for
Atopic Dermatitis
Location: Columbus GA, Birmingham AL, Dawsonville GA,
Sponsor: AbbVie

Sex: All

Age: 18 - 63

Code: NCT06389136

Phase3, Recruiting